Harvard Bioscience Inc (HBIO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Harvard Bioscience Inc Azioni (HBIO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	12.93% 24.51	28.15	25.36	28.76	29.98
Cost Of Revenue	17.65% 9.74	11.83	10.64	12.09	11.63
Gross Profit	9.51% 14.77	16.32	14.73	16.67	18.35
Operating Expenses	6.28% 17.05	16.04	15.66	15.88	16.60
Benefits Costs and Expenses	0.89% 29.00	29.26	25.93	30.86	28.77
Costs And Expenses	0.89% 29.00	29.26	25.93	30.86	28.77
Operating Income/Loss	908.16% -2.279	0.282	-0.933	0.796	1.749
Nonoperating Income/Loss	59.21% -2.205	-1.385	0.371	-2.894	-0.542
Income/Loss From Continuing Operations Before Tax	306.53% -4.484	-1.103	-0.562	-2.098	1.207
Income Tax Expense/Benefit	70.63% 0.21	0.715	0.677	-1.118	0.585
Income/Loss From Continuing Operations After Tax	158.20% -4.694	-1.818	-1.239	-0.98	0.622
Net Income/Loss	158.20% -4.694	-1.818	-1.239	-0.98	0.622
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	57,769% 43.40	0.075	42.69	42.35	42.12
Diluted Average Shares	57,769% 43.40	0.075	42.69	42.35	42.78
Basic Earnings Per Share	175.00% -0.11	-0.04	-0.03	-0.02	0.01
Diluted Earnings Per Share	175.00% -0.11	-0.04	-0.03	-0.02	0.01
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

AVTR

$20.18

2.70%

BAX

$33.02

3.32%

ALGN

$229.90

2.78%

HOLX

$78.79

0.24%

COO

$99.48

0.15%

WST

$307.21

2.31%